Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience.

ABSTRACT: Molecular tests have become an indispensable tool for the diagnosis and prognosis of hematological malignancies and are subject to accreditation according to the International Standard ISO 15189. National standardization of these techniques is essential to ensure that patients throughout France benefit from the same care. We report here on the experience of the GBMHM (Groupe des Biologistes Moléculaires des Hémopathies Malignes). By organizing External Evaluation of Quality (EEQ) programs and training meetings, the GBMHM has contributed to improvement and standardization of molecular tests in 64 French laboratories. A retrospective analysis of the quality-control results of 11 national campaigns spanning 10 years was performed for the 3 most frequently prescribed tests: BCR-ABL1<

SUBMITTER: Alary AS 

PROVIDER: S-EPMC8598224 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature